We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Implantable System Treats Cause of Chronic Back Pain

By HospiMedica International staff writers
Posted on 13 Jun 2016
Print article
Image: The implantation site of the ReActiv8 neurostimulator (Photo courtesy of Mainstay Medical).
Image: The implantation site of the ReActiv8 neurostimulator (Photo courtesy of Mainstay Medical).
An innovative implantable neurostimulation system helps treat disabling chronic low back pain (CLBP) via a handheld wireless remote control.

The ReActiv8 is a small implantable neurostimulation system, which excites the nerves responsible for contracting the key muscles that stabilize the lower back. The device is indicated as an adjunct to medical management of CLBP, and for pain relief in adults who have attempted at least on pervious medical management intervention and physical therapy. During the patient-controlled treatment sessions, ReActiv8 stimulation causes repetitive contractions of the key stabilizing muscles, support recovery from CLBP and its related symptoms.

In similar to other exercise programs used to restore muscle control, ReActiv8 is applied twice a day in 30-minute sessions; over time, the stimulated contractions can help the brain and body learn how to restore muscle control and spine stabilization. The ReActiv8 is a product of Mainstay Medical (Dublin, Ireland), and has received the European Community CE mark of approval.

“ReActiv8 is an innovative use of neurostimulation for the treatment of chronic low back pain and the clinical data from the ReActiv8-A trial are compelling,” said neurosurgeon and neurostimulation expert Stefan Schu, MD, of Sana Hospital (Duisburg, Germany). “Neurosurgeons in Germany have a track record of embracing important innovations, and we are looking forward to offering ReActiv8 to patients who until now were facing the prospect of disabling chronic low back pain for the rest of their lives.”

“We see several new chronic low back pain patients every week who are not indicated for surgery, and who meet the indications for ReActiv8,” said Robert Pflugmacher, MD, an orthopedic surgeon at University Hospital Bonn (Germany). “Rather than sending them home untreated, we now have an exciting new option we can offer them. As orthopedic surgeons, ReActiv8 meets our objective of addressing the underlying functional causes of chronic low back pain, and the straightforward implant procedure utilizes skills and techniques familiar to us.”

Related Links:
Mainstay Medical

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Digital Pump
Theia
New
Portable Patient Monitor
CMS9200PLUS

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.